Healthcare / Health Information ServicesHelsinki
$1.47
-0.04 (-2.65%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-3.7M · quality 77.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
20/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$32M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-27.6%
↓Gross Margin
63.6%
↑Debt/Equity
0.11
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.3%
FCF CAGR
—
FCF margin
-28.3%
FCF / Net income
0.73x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $17.1M · net income $-6.6M · FCF $-4.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $17.1M | $17.1M | $15.0M | $15.1M | $14.7M |
| Net Income | $-6.6M | $-6.6M | $-5.5M | $-4.4M | $-5.5M |
| EBITDA | $-4.1M | $-4.1M | $-2.9M | $-2.1M | $-2.3M |
| EPS | -0.34 | -0.34 | -0.29 | -0.27 | -0.37 |
| Gross Margin | 63.6% | 63.6% | 64.3% | 67.8% | 62.8% |
| Operating Margin | -35.3% | -35.3% | -39.6% | -26.3% | -34.8% |
| Net Margin | -38.8% | -38.8% | -36.2% | -29.4% | -37.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.11 | 0.11 | 0.16 | 0.24 | 0.33 |
| Current Ratio | 2.51 | 2.51 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.8M | $-4.8M | $-3.7M | $-3.0M | $-5.4M |
| Returns | |||||
| ROE | -27.6% | -27.6% | -23.1% | -21.8% | -26.9% |
| Valuation | |||||
| P/B | 1.21 | 1.21 | 3.66 | 3.05 | 3.04 |
| Growth & Yield | |||||
| Revenue Growth | 13.7% | 13.7% | -0.4% | 3.0% | — |
| EPS Growth | -17.2% | -17.2% | -7.4% | 27.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-64.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.29 → -0.34
Residual
-64.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.